Market Overview

Animal Model Market is projected to achieve a value of USD 2,846 Million in 2023, with a linear behavior in the market growth it is forecasted to achieve a value of USD 4,923 Million by 2033 with a CAGR of 7.4% during the forecast period 2023-2033.

Animal model is a model in which use of non-human, living and genetically similar or engineered animal instated of human being for the scientific purpose or to investigation of human diseases. Moreover, animal is used to study and research the impact of diseases and novel drugs reaction on the body without harm any human beings.

Animal model provide an important platform to researcher to understand and study the pharmacokinetic and pharmacodynamics effect, complex and adverse action and efficacy of drug. Moreover, its play an important role in investigation of various types of infectious diseases like hepatitis, influenza, HIV, Zica virus etc. For instance, based on a 2022 publication from the National Library of Medicine, various small animal models such as mice, Syrian hamsters, guinea pigs, and ferrets are used to investigate the virulence, transmission, and immune characteristics of both seasonal and pandemic influenza viruses.

Increasing the number of pharmaceutical research and developments activities, increasing the prevalence of human diseases and government initiatives to funding toward novel drug discovery anticipated to drive the growth of animal model market. Moreover, animal plays an important role in virology research, allowed scientist to mimic human infection and to assist the effect and efficacy of antiviral drug or vaccines.

For instance, During the COVID-19 pandemic, animal models played a crucial role in enhancing our comprehension of the SARS-CoV-2 virus and assessing potential treatment strategies. Moreover, as per data from the Congressional Budget Office, the pharmaceutical industry allocated approximately $83 billion towards research and development (R&D) endeavors in the year 2019.

Additionally, Significant advancements in various stages of animal model production, including technologies like enhanced fertilized egg injection and ovulation promotion methods, are poised to contribute to the expansion of the industry. These enhancements in genome editing tools have facilitated the creation of a greater number of complex genetically modified models, thus promoting market growth.

Market Scope

Market Dynamics

The similarities in physiological attributes between humans and animals has long been acknowledged the growth of animal models in drug testing. Mammals, in particular, exhibit numerous fundamental biological systems and processes akin to those in humans, rendering them invaluable for scrutinizing the effectiveness and safety of potential pharmaceutical treatments. A pivotal shared aspect is the general structure and operation of major organ systems.

Additionally, to reduce the negative impact of the pandemic, traditionally operated organizations have proactively embraced collaboration opportunities to enhance their capacity for supporting hybrid models. These initiatives have been instrumental in sustaining clinical research and development efforts, ensuring the continued utilization of animal models, thus contributing to the animal model market growth.

The ongoing utilization of rats in scientific experiments has brought heightened scrutiny to the ethical treatment of these valuable beings. Stringent regulations and guidelines governing the use of animals for the betterment of humanity pose challenges to the expansion of the global market. For instance, in 2019, Australia implemented a ban on the use of animal test data for cosmetics. The state of Minas Gerais in Brazil also took a significant step in 2018 by prohibiting cosmetic animal experiments. Furthermore, Sri Lanka passed legislation aimed at animal protection.

The animal model market experienced a favorable upswing in growth due to the COVID-19 pandemic. Substantial investments and grants from both governmental bodies and major industry players were directed towards the advancement of detection and treatment strategies for COVID-19 infections. This surge in funding was directly linked to the escalation of research efforts aimed at creating innovative vaccines and diagnostics. For instance, In the year 2020, Mirimus Inc., a pioneering American company specializing in the creation of animal models, revealed its partnership with an academic research team.

Market By Application Analysis

By Application, the Animal Model Market is Categories into Research & Development, Production, and Quality Control. The Research & Development segment accounts for the largest share of around 41% in 2022.

Over the forecast period, a steady increase in revenue is expected, driven by the growing demand from laboratories across the globe. This demand is particularly driven by the need for toxicity testing and the conduct of research in areas such as nutrition, immunology, neurology, and genetics, both for basic and applied studies.

Market By Animal Type Group Analysis

By Animal Type, the Animal Model Market is Categories into Pigs, Cats, and Mice. The Mice segment accounts for the largest share of around 77% in 2022.

Among the other animal it is estimated that 90% are either mice or rats, with mice being the predominant choice in academic and pharmaceutical investigations. Their popularity is attributed to their small size, short lifespan, quick reproductive cycle, gentle nature, and docility. Additionally, their well-understood biology, physiology, anatomy, genetic mapping, and ease of genetic modification make them highly suitable models for study purposes.

Market By Technology Analysis

By Technology, the Animal Model Market is Categories into CRISPR, Microinjection, and Embryonic Stem Cell Injection. The CRISPR segment accounts for the largest share of around 57% of the Market in 2022.

CRISPR, a set of DNA sequences, is found within the genomes of prokaryotic organisms, including bacteria and archaea. These sequences are originally derived from DNA fragments of previously infecting bacteriophages in the prokaryote. They play a crucial role by locating and removing DNA from similar bacteriophages during subsequent infections, thereby contributing to market growth.

Market By End-User Analysis

By End-User, the Animal Model Market is Categories into Research Institutes, Educational Institutes, Pharmaceutical Companies, and Contract Research Organizations. The Pharmaceutical Companies segment accounts for the largest share of around 62% in 2022.

Pharmaceutical companies play a vital role in research with personal research and development infrastructure. The expanded use of the rat model in the research and development pipeline, particularly in the production of drugs and vaccines for autoimmune disorders and infectious diseases, has led to increased revenue generation.

Market Regional Analysis

North America dominate the Animal Model Market with the highest revenue generating market with share of more than 43%. The increasing prevalence of chronic illnesses, the emergence of new infectious strains, and the growing economic investments on healthcare in North America are expected to support research efforts in the region. Furthermore, the expansion of research activities conducted by research and academic institutions is anticipated to drive regional growth.

The animal model market in Europe holds the second-largest market share, with a significant concentration of toxicological, nutritional, immunological, and medical laboratories in the region expected to drive revenue growth. Specifically, the market in Germany is the largest in the region, while the market in the United Kingdom is the fastest-growing within Europe.

Asia-Pacific is estimated the fastest growing CAGR in Animal Model Market in forecasted period. The growth in market revenue can be attributed to features like ease of manipulation, short lifespan, and high reproducibility, which have gained adoption in various industries throughout the Asia-Pacific region. Notably, the animal model industry in China claims the largest market share, while the market in India is experiencing the fastest growth among countries in the Asia-Pacific region.

Competitive Analysis

The Animal Model Market is dominated by a few large companies, such as The Jackson Laboratory., Hera Biolabs, Ozgene Pty Ltd., Trans Genic Inc., Genoway S.A., Taconic Biosciences, Janvier Labs, LLC, Inotiv, Inc., Charles River Laboratories, Crown Bioscience Inc.

There Are Some Of The Recent Developments Of The Animal Model Market:

In Aug 2016, Charles River Laboratories, Inc. has established a strategic partnership with The Milner Therapeutics Institute and Consortium in the UK. This collaboration provides academic institutions with access to Charles River's early discovery and drug development services, supporting early-stage drug development processes.

In Sept 2016, Charles River Laboratories International, Inc. has acquired Agilux Laboratories in the United States, a company specializing in bioanalytical services, drug metabolism, pharmacokinetic services, and pharmacology services. This acquisition is anticipated to enhance Charles River's non-clinical offerings and support clients in their early-stage research endeavors by facilitating the smooth progression of their drug candidates through the discovery and safety assessment phases.

February 2022, Genoway S.A. partners with a leading academic institution to develop new animal models for neurological disorders.

By Application

·         Research & Development

·         Production

·         Quality Control

By Animal Type

·         Pigs

·         Cats

·         Mice

By Technology

·         CRISPR

·         Microinjection

·         Embryonic Stem Cell Injection

By End-User

·         Research Institutes

·         Educational Institutes

·         Pharmaceutical Companies

·         Contract Research Organizations